AstraZeneca | Investor Conference Presentation Deck

Slide schematic 6/6

callout 1/1 chart 1/1 image 1/1 paragraph 1/1 source-note 1/1 title 1/1

Components 6

primary line illustration paragraph source-note headline

Tools 1

The slide presents a new therapeutic candidate, AZD5335, and highlights its promising preclinical results, aiming to capture the audience's attention and interest.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

before-after-framing 90%

Comparison of MTI vs TOP1i efficacy in resistant models

Find anything

The slide uses a before-after comparison of drug efficacy (MTI vs TOP1i) and a diagram of the ADC structure.